model: gpt-4-1106-preview
prompt: Write a paragraph of text in the style of a biomedical research article. Include the following protein complex name: IDH. Use this name exactly as provided, avoiding any synonyms, aliases, abbreviated or expanded forms. Also avoid including any other names referring to a gene, protein, protein complex, protein part or component, or any other molecular entity containing amino acid residues. The text can include mentions of other biomedical entity types, such as chemical, organism, and disease names.
output: In the ongoing investigation of metabolic alterations in oncological pathologies, recent studies have highlighted the significance of the IDH protein complex in cellular metabolism and its potential link to the development of certain cancer types. The enzyme's role in catalyzing the oxidative decarboxylation of isocitrate to Î±-ketoglutarate presents a critical metabolic crossroad that intersects with both energy production and biosynthetic processes. Dysregulation of IDH activity has been implicated in a spectrum of malignancies, prompting a closer examination of its kinetic properties and regulatory mechanisms. Notably, the discovery of small molecule inhibitors that selectively target the IDH complex has opened new avenues for therapeutic intervention. Through a combination of crystallography, in vitro assays, and in vivo models, substantial progress has been made in elucidating the precise molecular interactions that govern IDH function and its distortion in disease states, offering the promise of more effective, targeted treatments for patients suffering from IDH-associated cancers. With the heightened specificity of these inhibitors, clinical trials are underway to assess their efficacy, tolerability, and pharmacokinetics in the context of personalized medicine.
